Browse Studies — Arctuva

An Observational Multi-Center Study to Evaluate Real-World Treatment Outcomes With or Without Durvalumab-Based Regimens in Hepatobiliary Cancers

Given the number of anticipated durvalumab-based treatment launches in the hepatobiliary cancer space over the next 3 years, there is a need to capture contemp…

Hepatobiliary Cancers

Estimated

~$10 – $1,125

AstraZenecaNCT06252753

Observational

Pilot Trial Comparing Circulating Tumor DNA (ctDNA) From Immediate Draining Vein vs. Standard Peripheral Vein Sample in Patients Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

This is a prospective pilot protocol investigating whether ctDNA detection be improved by sampling the cancer draining vein versus the standard practice of sam…

Hepatobiliary CancerPancreatic CancerHepatocellular Carcinoma+3 more

Estimated

~$10 – $6,250

University of California, IrvineNCT05497531

Observational

Targeted Navigation to Achieve Health Equity: Increasing Access to Care, Patient Engagement and Research Participation

The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the…

Hepatocellular CarcinomaCholangiocarcinomaHepatobiliary Cancer

Estimated

~$10 – $6,250

University of MiamiNCT06260943

cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual Disease, and Relapse

This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differenti…

Brain CancerBreast CancerBladder Cancer+17 more

Estimated

~$10 – $1,050

Adela, IncNCT05366881